SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
World game at war: why some European nations have threatened a World Cup boycott 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
 - EconoTimes)
Dublin, May 08, 2018 -- The "Point-of-Care Diagnostics & Biosensors Europe 2018" conference has been added to ResearchAndMarkets.com's offering.
Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- Wearable and Implantable Devices
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing
For more information about this conference visit https://www.researchandmarkets.com/research/nqcksd/european?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Point-of-Care Diagnostics
